NEDD4L
Disease associated variation - ClinVar
Allele IDTypeNameRS#dbSNPPhenotype IDsChromosomeStartStopReferenceAlternate
167274deletionNM_001144967.2(NEDD4L):c.297+16701_297+17823del-1MedGen:CN220684185826875558269877nana
167274deletionNM_001144967.2(NEDD4L):c.297+16701_297+17823del-1MedGen:CN220684185593598755937109nana
227105single nucleotide variantNM_001144967.2(NEDD4L):c.2036A>G (p.Tyr679Cys)879255599MedGen:CN239092,OMIM:617201;MedGen:CN236338185603343356033433AG
227105single nucleotide variantNM_001144967.2(NEDD4L):c.2036A>G (p.Tyr679Cys)879255599MedGen:CN239092,OMIM:617201;MedGen:CN236338185836620158366201AG
227106single nucleotide variantNM_001144967.2(NEDD4L):c.2082G>T (p.Gln694His)879255598MedGen:CN239092,OMIM:617201;MedGen:CN236338185836776458367764GT
227106single nucleotide variantNM_001144967.2(NEDD4L):c.2082G>T (p.Gln694His)879255598MedGen:CN239092,OMIM:617201;MedGen:CN236338185603499656034996GT
227107single nucleotide variantNM_001144967.2(NEDD4L):c.2677G>A (p.Glu893Lys)879255597MedGen:CN239092,OMIM:617201;MedGen:CN236338185839066758390667GA
227107single nucleotide variantNM_001144967.2(NEDD4L):c.2677G>A (p.Glu893Lys)879255597MedGen:CN239092,OMIM:617201;MedGen:CN236338185605789956057899GA
227108single nucleotide variantNM_001144967.2(NEDD4L):c.2690G>A (p.Arg897Gln)879255596MedGen:CN239092,OMIM:617201;MedGen:CN236338185605791256057912GA
227108single nucleotide variantNM_001144967.2(NEDD4L):c.2690G>A (p.Arg897Gln)879255596MedGen:CN239092,OMIM:617201;MedGen:CN236338185839068058390680GA
227795single nucleotide variantNM_001144968.1(NEDD4L):c.24G>A (p.Gln8=)4149601MedGen:CN236526;MedGen:CN236559185814955958149559GA
227795single nucleotide variantNM_001144968.1(NEDD4L):c.24G>A (p.Gln8=)4149601MedGen:CN236526;MedGen:CN236559185581679155816791GA
243078single nucleotide variantNM_015277.5(NEDD4L):c.639C>T (p.Asn213=)202008394MedGen:CN169374185599235355992353CT
243078single nucleotide variantNM_015277.5(NEDD4L):c.639C>T (p.Asn213=)202008394MedGen:CN169374185832512158325121CT
243079single nucleotide variantNM_015277.5(NEDD4L):c.2692+6C>T12964776MedGen:CN169374185605798056057980CT
243079single nucleotide variantNM_015277.5(NEDD4L):c.2692+6C>T12964776MedGen:CN169374185839074858390748CT
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
1855810733rs549476AGrs5494763.00E-06DEXTROAMPHETAMINEPLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONEResponse to amphetaminesHPOID:0000707DOID:670AintronGWASdb_drug
1855828612rs8088164TCrs80881645.33E-05ALDOSTERONEBIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENINBlood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763TintronGWASdb_drug
1855910523rs158856CTrs1588567.00E-06CAFFEINERECEPTOR, ADENOSINE A2A|PRIMA1 PROTEIN, HUMAN|NERVE TISSUE PROTEINS|MEMBRANE PROTEINSInsomnia (caffeine-induced)HPOID:0100785DOID:8611CintronGWASdb_drug
1855915325rs2288772GArs22887721.00E-04TOPIRAMATE|FRUCTOSEANTICONVULSANTSCognitive impairment induced by topiramateHPOID:0100543DOID:1561AintronGWASdb_drug
1855938204rs7230600GArs72306009.14E-04ALDOSTERONEBIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENINBlood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763AintronGWASdb_drug
1855941906rs4941373GCrs49413738.50E-06TESTOSTERONELIN-28 PROTEIN, HUMAN|BIOLOGICAL MARKERS|RNA-BINDING PROTEINSDigit length ratioHPOID:0000818DOID:12849|DOID:1094|DOID:15|DOID:9970|DOID:9352|DOID:1287GintronGWASdb_drug
1855957987rs4058295CArs40582958.30E-06TESTOSTERONELIN-28 PROTEIN, HUMAN|BIOLOGICAL MARKERS|RNA-BINDING PROTEINSDigit length ratioHPOID:0000818DOID:12849|DOID:1094|DOID:15|DOID:9970|DOID:9352|DOID:1287CintronGWASdb_drug
1855983364rs2288775AGrs22887755.50E-06TESTOSTERONELIN-28 PROTEIN, HUMAN|BIOLOGICAL MARKERS|RNA-BINDING PROTEINSDigit length ratioHPOID:0000818DOID:12849|DOID:1094|DOID:15|DOID:9970|DOID:9352|DOID:1287GintronGWASdb_drug
1856041732rs7242150TGrs72421508.10E-04ATORVASTATINSERINE ENDOPEPTIDASES|PYRROLES|PCSK9 PROTEIN, HUMAN|HEPTANOIC ACIDS|APOLIPOPROTEINS E|PROPROTEIN CONVERTASESResponse to statin treatment (atorvastatin), change in cholesterol levelsHPOID:0001626DOID:1287TintronGWASdb_drug
1855720220rs8097619CTrs80976196.33E-04Insulin resistanceHPOID:0000855DOID:9352TintronGWASdb_trait
1855721004rs9989622CGrs99896229.89E-04Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
1855721004rs9989622CGrs99896226.89E-04Insulin resistanceHPOID:0000855DOID:9352GintronGWASdb_trait
1855775343rs1787777TCrs17877776.11E-04Type 2 diabetesHPOID:0005978DOID:9352CintronGWASdb_trait
1855783497rs529445CArs5294453.00E-06Amyotrophic lateral sclerosis (sporadic)HPOID:0007354DOID:332CintronGWASdb_trait
1855784763rs554192AGrs5541922.24E-04Premature ovarian failureHPOID:0008209DOID:5426TintronGWASdb_trait
1855810733rs549476AGrs5494763.00E-06Response to amphetaminesHPOID:0000707DOID:670AintronGWASdb_trait
1855811058rs878396GArs8783963.85E-05AtopyHPOID:0001047DOID:0060056GintronGWASdb_trait
1855828612rs8088164TCrs80881645.33E-05Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763TintronGWASdb_trait
1855903021rs158865CTrs1588651.97E-05Crohn's diseaseHPOID:0100280DOID:8778TintronGWASdb_trait
1855903721rs158862CTrs1588625.71E-04Multiple complex diseasesHPOID:0000118NACintronGWASdb_trait
1855909630rs17064520CTrs170645203.22E-07AsthmaHPOID:0002099DOID:2841CintronGWASdb_trait
1855910523rs158856CTrs1588567.00E-06Insomnia (caffeine-induced)HPOID:0100785DOID:8611CintronGWASdb_trait
1855912732rs646509ACrs6465091.20E-16Health and aging, CVD and cancer age of onsetHPOID:0002664|HPOID:0001626DOID:1287|DOID:162AmissenseGWASdb_trait
1855912732rs646509ACrs6465092.50E-34Health and aging, CVD and cancer age of onsetHPOID:0002664|HPOID:0001626DOID:1287|DOID:162AmissenseGWASdb_trait
1855912732rs646509ACrs6465092.60E-07Health and aging, CVD and cancer age of onsetHPOID:0002664|HPOID:0001626DOID:1287|DOID:162AmissenseGWASdb_trait
1855912732rs646509ACrs6465092.70E-47Health and aging, CVD and cancer age of onsetHPOID:0002664|HPOID:0001626DOID:1287|DOID:162AmissenseGWASdb_trait
1855915325rs2288772GArs22887721.00E-04Cognitive impairment induced by topiramateHPOID:0100543DOID:1561AintronGWASdb_trait
1855936104rs1453082GTrs14530822.03E-05Endometrial cancerHPOID:0012114DOID:1380CintronGWASdb_trait
1855936104rs1453082GTrs14530826.61E-05Endometrial cancerHPOID:0012114DOID:1380CintronGWASdb_trait
1855936104rs1453082GTrs14530828.91E-05Endometrial cancerHPOID:0012114DOID:1380CintronGWASdb_trait
1855937757rs12604734TCrs126047343.50E-05Diabetic retinopathyHPOID:0000819|HPOID:0000488DOID:8947TintronGWASdb_trait
1855941906rs4941373GCrs49413738.50E-06Digit length ratioHPOID:0000818DOID:12849|DOID:1094|DOID:15|DOID:9970|DOID:9352|DOID:1287GintronGWASdb_trait
1855957987rs4058295CArs40582958.30E-06Digit length ratioHPOID:0000818DOID:12849|DOID:1094|DOID:15|DOID:9970|DOID:9352|DOID:1287CintronGWASdb_trait
1855959751rs9952789GCrs99527899.00E-05Diabetic retinopathyHPOID:0000819|HPOID:0000488DOID:8947GintronGWASdb_trait
1855983364rs2288775AGrs22887755.50E-06Digit length ratioHPOID:0000818DOID:12849|DOID:1094|DOID:15|DOID:9970|DOID:9352|DOID:1287GintronGWASdb_trait
1855988294rs7243164GArs72431641.65E-04Type 2 diabetesHPOID:0005978DOID:9352GintronGWASdb_trait
1855991546rs10503022TCrs105030226.10E-05Diabetic retinopathyHPOID:0000819|HPOID:0000488DOID:8947TintronGWASdb_trait
1855995721rs4058287AGrs40582879.29E-06NephrolithiasisHPOID:0000787DOID:585A,GintronGWASdb_trait
1856009604rs12454023CTrs124540238.00E-07Migraine with auraHPOID:0002077DOID:10024CintronGWASdb_trait
1856009604rs12454023CTrs124540238.66E-04Migraine - clinic-basedHPOID:0002076DOID:6364CintronGWASdb_trait
1856041732rs7242150TGrs72421508.10E-04Response to statin treatment (atorvastatin), change in cholesterol levelsHPOID:0001626DOID:1287TintronGWASdb_trait
1856051135rs8098336TCrs80983367.13E-05Cognitive test performanceHPOID:0100543DOID:1561TintronGWASdb_trait
1856063153rs6566965CTrs65669653.34E-05Cognitive test performanceHPOID:0100543DOID:1561CintronGWASdb_trait
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000049759.17 NEDD4L 606384